Around 40% of the human genome is subject to patents, researchers say |
The court quashed patents held by a Utah-based firm on two genes linked to breast and ovarian cancer.
The opinion said DNA came from nature and was not eligible for patenting.
The US biotechnology industry had warned any blanket ban on such patents would jeopardise huge investment in gene research and therapies.
0 comments:
Post a Comment
Grace A Comment!